Almanack Investment Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,455
| Closed | -$346K | – | 474 |
|
|
2020
Q4 | $346K | Buy |
2,455
+64
| +3% | +$9.02K | 0.04% | 268 |
|
|
2020
Q3 | $292K | Buy |
+2,391
| New | +$292K | 0.04% | 299 |
|
|
2018
Q4 | – | Sell |
-4,980
| Closed | -$425K | – | 263 |
|
|
2018
Q3 | $425K | Buy |
4,980
+2,170
| +77% | +$185K | 0.11% | 99 |
|
|
2018
Q2 | $267K | Sell |
2,810
-2,458
| -47% | -$234K | 0.12% | 79 |
|
|
2018
Q1 | $461K | Sell |
5,268
-1,484
| -22% | -$130K | 0.18% | 49 |
|
|
2017
Q4 | $575K | Buy |
6,752
+1,806
| +37% | +$154K | 0.23% | 50 |
|
|
2017
Q3 | $428K | Sell |
4,946
-8,756
| -64% | -$758K | 0.21% | 52 |
|
|
2017
Q2 | $1.06M | Buy |
13,702
+8,696
| +174% | +$671K | 0.59% | 45 |
|
|
2017
Q1 | $347K | Buy |
+5,006
| New | +$347K | 0.26% | 65 |
|